Treatment type | Agent | Authors | Study Type | Sample size (n) | Main findings |
---|---|---|---|---|---|
Antioxidant treatments | Lycopene | Karemore T. V. and Motwani M [55]. | Single blinded prospective study | 92 | Ingestion of 8 g/QD of lycopene (n = 46) for three months was shown to be effective in the reduction of burning mouth and mouth opening (p < 0.05) in patients with OSMF when compared to the placebo group (n = 46). |
Curcumin | Hazarey V. et al. [56] | Randomized control clinical trial | 30 | Sucking 2 g/QD of Curcumin lozenges (n = 15) with physiotherapy for three months showed a significant improvement in both mouth opening and in alleviating the burning sensation (p < 0.05) in comparison to the control group (clobetasol propionate 0.05%; (n = 15). | |
Micronutrient therapy | Maher R. et al. [57] | Single arm preliminary prospective study | 117 | Swallowing micronutrient supplements: vitamins A, B complex, C, D, E; and minerals iron, calcium, copper, zinc, and magnesium was observed to be significantly effective (p < 0.05) in reduction of sign and symptoms of OSMF over 3 years. | |
Spirulina and Aloe Vera | Patil S. et al. [58] | Double blinded prospective study | 42 | Ingestion of 500 mg/QD of Spirulina (n = 21) for 3 months was associated with a significant improvement in mouth opening and reduction in ulcers/erosions/vesicles (p < 0.05) in comparison to 5 mg of aloe vera (n = 21) for the same time. Improvement in burning sensation and pain associated with lesions was not found significant between two groups | |
Alam S. et al. [59] | Double-blinded, placebo- controlled, parallel-group randomized controlled trial | 60 | Application of aloe vera gel over buccal mucosa, palate, retromolar region, and floor of the mouth twice daily during submucosal injection of hyaluronidase and dexamethasone (n = 15) and surgical treatment (buccal fat pad, nasolabial flap, or collagen membrane, (n = 15) treatment with 6 months of follow up was observed to be a significant adjuvant therapy in reduction of most of the symptoms of OSMF (p < 0.01), in comparison to a similar group of medicines alone, (n = 15) and surgical procedures (n = 15)] with no application of aloe vera. | ||
Medicinal treatments | Steroids | Goel S. et al. [60] | Longitudinal prospective study | 270 | 4 mg/ml/biweekly injections of Betamethasone diluted in 1.0 ml of 2% xylocaine for 6 months given on buccal mucosa, bilaterally, using an insulin syringe, with a half dose on each side, was showed significant improvement of mouth opening and reduction in burning sensation in a stage II and stage III OSMF group (p < 0.0001), in comparison to a control group which received no treatment over two years. |
Hyaluronidase | James L. et al. [61] | Retrospective study | 28 | Intralesional injection of Hyaluronidase 1500 IU mixed in 1.5 ml of dexamethasone and 0.5 ml of lignocaine hydrochloride biweekly for 4 weeks showed a significant improvement in mouth opening with net gain of 6 ± 2 mm (92%), reducing the burning sensation (89%), number of painful ulceration (78%) and blanching of oral mucosa (71%) for Grade III OSMF patients. | |
Colchicine + Hyaluronidase | Krishnamoorthy B. & Khan M [62]. | Comparative prospective study | 50 | 1 mg/ day colchicine tablet and 0.5 ml intralesional Injection hyaluronidase 1500 IU/ once a week (group I, n = 25) for twelve weeks showed a significant improvement in mouth opening (p < 0.05) and reduced burning sensation (33% by second week) in comparison to subjects treated with 0.5 ml intralesional injection of hyaluronidase 1500 IU and 0.5 ml intralesional injection hydrocortisone acetate 25 mg/ml once a week alternatively (group II, n = 25). | |
Placental extracts | Singh P. et al. [63] | Comparative prospective study | 10 | 2 ml intralesional placental extract mixed with 2 ml of 2% lignocaine HCL weekly for an interval of 8 weeks showed an average improvement in mouth opening by 8.02 mm (average pretreatment mouth opening = 18.49 mm, average posttreatment mouth opening = 26.51 mm) with average marked reduction in burning sensation by 4.9 (average pretreatment burning sensation = 8.0, average posttreatment burning sensation = 3.1). Burning sensation was assessed using visual analogue scale with 0–10, where 0 = no burning sensation and 10 = maximum burning sensation. | |
Isoxupurine | Bhadage C. J. et al. [64] | Prospective study | 40 | 10 mg Isoxsuprine tablets/ QID with oral physiotherapy (Group A, n = 15) plus 2 ml dexamethasone by intralesional injection with 1500 IU hyaluronidase mixed with 1 ml of 2% lignocaine solution with adrenaline 1:80,000 (Group B, n = 15) for six weeks with a follow up of 4 months, showed a significant improvement in mouth opening (p < 0.05) and burning sensation (p < 0.00001) in comparison to the placebo group (only oral physiotherapy) (Group C, n = 10). | |
Pentoxifylline | Rajendran R. et al. [65] | Randomized controlled clinical trial | 29 | 400 mg/ TID of Pentoxifylline tablets (n = 14) for seven months showed a significant improvement in mouth opening (p < 0.0001), tongue protrusion (p < 0.05), relief from perioral fibrotic bands (p < 0.0001), subjective symptoms of intolerance to spices (p < 0.0001), burning sensation of mouth (p < 0.0001), tinnitus (p < 0.0001), difficulty in swallowing (p < 0.0001) and difficulty in speech (p < 0.0001) in comparison to the control group (multivitamin with local heat therapy, n = 15). | |
Oral physiotherapy | Ultrasound + Physiotherapy | Kumar V. et al. [66] | Single arm prospective study | 15 | Ultrasound therapy with 0.7–1.5 W/Cm2 with thumb kneading physiotherapy for six days/ week for two consecutive weeks showed significant improvement in mouth opening (p < 0.001) and reduction of burning sensation. |
Surgical approaches | Surgery | Kamath V. V [67]. | Systematic Review | – | Lasers, tongue flap, palatal flap, buccal fat pad, nasolabial flap, thigh flaps, split skin grafts, collagen membrane, artificial dermis, human placenta grafts, coronoidectomies, muscle myotomies and oral stents. All surgeries have shown significant improvement in the symptoms of OSMF. However there exist no definite protocols and thus author comments that treatment remains subjective to the operating surgeon. |